INDEPENDENT INTELLIGENCE
LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Cumberland Pharmaceuticals Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERCPIX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / CPIX COVERAGE

What’s moving Cumberland Pharmaceuticals Inc. now

Current reporting with the operating signal separated from the noise.

01
Cumberland Pharmaceuticals Inc. (CPIX) Q2 2026 Earnings Call Transcript

Cumberland Pharmaceuticals Inc. (CPIX) Q2 2026 Earnings Call Transcript

Investors are testing whether Cumberland Pharmaceuticals Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
02
Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports Q1 2026 Financial Results & Company Update

Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Reports Q1 2026 Financial Results & Company Update

The story matters when it changes Cumberland Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex

Cumberland Pharmaceuticals Inc.: Cumberland Pharmaceuticals Announces Strategic Transaction to Integrate Commercial Business with Apotex

The story matters when it changes Cumberland Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
04
Cumberland Pharmaceuticals Inc. (CPIX) Chief Executive Officer A.J. Kazimi to Ring the NASDAQ Stock Market Closing Bell

Cumberland Pharmaceuticals Inc. (CPIX) Chief Executive Officer A.J. Kazimi to Ring the NASDAQ Stock Market Closing Bell

Investors are testing whether Cumberland Pharmaceuticals Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
PRIMARY DOCUMENTS / SEC EDGAR

Latest CPIX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-08 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-07 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-09 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-08-04 · Period 2026-08-04SEC ↗8-KMaterial company eventFiled 2026-07-13 · Period 2026-07-13SEC ↗8-KMaterial company eventFiled 2026-07-01 · Period 2026-06-29SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-03-09 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-25 · Period 2026-06-24SEC ↗
EARNINGS / QUARTERLY TRACKER

Cumberland Pharmaceuticals Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.